Articles tagged with Biomarkers
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Alzheimer's disease is a neurodegenerative disorder characterized by memory problems, orientation issues, and behavioral changes. A simplified diagnosis using specific biomarkers improves the accuracy of early-stage diagnoses.
A Dartmouth College study found that infant toenails are a reliable way to estimate arsenic exposure before birth. The researchers used plasma mass spectrometry to analyze infant toenails and found a significant correlation between maternal and infant toenail arsenic concentrations.
Researchers at Johns Hopkins Bayview Medical Center introduced guidelines and changes to the computerized provider order entry system to reduce redundant biomarker testing. This led to a 66% decrease in tests ordered and saved an estimated $1.25 million in laboratory charges.
Researchers analyzed ancient Neanderthal fecal matter, revealing significant plant intake alongside meat consumption. The study provides new insights into the role of vegetables in the Neanderthal diet.
Researchers developed a unique method to identify oil spills, even after most of it has degraded. They found that some biomarkers degrade within a few years after an oil spill, providing a window into the environment's impact.
Researchers discovered altered salivary biomarker levels in obese children, indicating a potential non-invasive method for identifying early Type 2 diabetes risk. The study's findings provide valuable insights into childhood obesity and metabolic syndrome, paving the way for development of prevention strategies.
Scientists have identified four microRNAs that can aid in the differential diagnosis of malignant pleural mesothelioma (MPM) from non-cancerous pleural tissue. The biomarkers, miR-126, miR-143, miR-145, and miR-652, were found to classify tissue samples with high accuracy.
The ASU Biodesign Institute has developed a high-quality biomarker discovery core competency to identify and select biomarkers for radiation biodosimetry. The team is now optimizing the assay panel and platform workflow to prepare for regulatory clearance from the FDA.
Research found pregnant women with polycystic ovary syndrome (PCOS) exhibit low-grade inflammation, worsening during pregnancy. This abnormal inflammation may contribute to increased risk of pregnancy complications like pre-eclampsia and gestational diabetes.
The American Association of Pharmaceutical Scientists recognizes outstanding researchers in biotechnology with various awards, including the AAPS Excellence in Ligand Binding Assays Award and the Innovation in Biotechnology Awards. These honors celebrate groundbreaking contributions to pharmaceutical biotechnology.
Scientists have developed a device that can process whole blood and isolate genetic material for two potential biomarkers within minutes. This rapid detection method could help determine the course of proper treatment, potentially saving lives.
A blood test using high-sensitivity cardiac troponin T can accurately predict heart attack risk in patients with chest pain, allowing for targeted admissions and reduced hospital costs. The test's negative predictive value was found to be 99.8 percent for heart attack within 30 days.
Researchers suggest aspartic acid could serve as a biomarker for postoperative cognitive dysfunction, based on correlation analysis between changes in hippocampal metabolites and cognitive impairment in aged rats. The study aims to identify potential biomarkers for predicting postoperative cognitive dysfunction.
A team of researchers identified two biomarkers that accurately predict a patient's response to radiation therapy, offering new hope for personalized treatment. The study published in the European Journal of Cancer found these markers can help avoid unnecessary side effects and reduce morbidity.
Researchers identified salivary biomarkers associated with gingivitis, including PGE2 and IL-1. These findings have implications for personalized oral health care, suggesting potential discrimination between gingivitis and health through salivary biomarker analysis.
Researchers use shrink wrap to boost signal of fluorescent markers in biosensing, enabling detection of infectious diseases with lower limits of detection. The technique could lead to a low-cost, highly sensitive diagnostic device using common, everyday materials.
A collaborative study has identified metabolomic biomarkers in urine and serum samples of women with preeclampsia, suggesting an early metabolic profile difference from women with normal pregnancies. The findings may lead to earlier detection and potentially prevent the disease.
Researchers at Washington University School of Medicine found that biomarkers of neuronal injury in Alzheimer's disease decrease as symptoms of dementia appear, contrary to previous findings. This reversal suggests a slowing of cell death and may be an important criterion for assessing the success of treatment trials.
A study published in Neurology found that patients with restless legs syndrome had a higher mortality rate than similar men, and were more likely to be diagnosed with cardiovascular disease and hypertension. RLS screening may become more common as a tool for primary care providers to identify patients at risk of serious disease.
Researchers at NUS created a highly sensitive fluorescence probe to detect Monoamine Oxidase B (MAO-B) activity, which is elevated in patients with Parkinson's disease. The probe can monitor the progression of the disease and has potential as a biomarker.
A new study by Mercyhurst University, UPMC Hamot, and Shriners Hospitals for Children is exploring the correlation between pitch count and throwing arm injuries. The researchers will use high-speed motion-capture cameras, shoulder muscle power tests, and biomarkers to analyze the effects of consecutive pitches on fatigue.
A new scientific blood analysis uses biomarkers and NMR spectroscopy to predict short-term mortality in the next five years. The study found that biomarker concentrations are crucial for normal metabolism, regardless of known risk factors.
Researchers have identified four biomarkers in blood samples that can predict mortality from any disease within five years. The study used NMR spectroscopy to analyze over 17,000 healthy individuals and found that these biomarkers were independent of traditional risk factors, indicating a general frailty in the body.
A new paper diagnostic for cancer has been developed by MIT engineers, which can detect the disease in minutes using a urine sample. The technology relies on nanoparticles that interact with tumor proteins, releasing biomarkers that are easily detectable in urine.
Researchers have identified a biological marker for major depression in teenage boys, combining elevated cortisol levels with depressive symptoms. The study found that these individuals are up to fourteen times more likely to develop major depression than those without these traits.
Human mesenchymal stem cells can undergo spontaneous tumorigenic transformation during cell culture expansion, a finding with significant implications for their clinical application. Researchers identified RNA molecule signatures that may serve as biomarkers to detect these aberrant cells.
Researchers Sarj Patel and Tom Rau aim to identify biomarkers of TBI through blood samples, improving diagnosis and treatment. The goal is to understand how localized injuries affect the entire brain.
Researchers discovered methylation sites linked to hypoxia, immune response, and neuronal differentiation in schizophrenia patients, offering potential avenues for distinct subtype identification and personalized treatment responses.
Researchers at NUS have discovered a biomarker called adenosine deaminase acting on RNA-1 (ADAR1) to diagnose and treat esophageal squamous cell carcinoma (ESCC). ADAR1 over-expression promotes tumor development, with clinical implications for early detection and treatment.
A recent study published in the Journal of the American College of Radiology reveals that there is minimal change in regional variation of imaging utilization between 2007 and 2011. In contrast, regional variation in imaging costs and other major health services categories remains significant.
Measuring changes in proteins in people with amyotrophic lateral sclerosis (ALS) may better predict disease progression, according to scientists at Penn State College of Medicine. Biomarkers from plasma and cerebrospinal fluid identified as useful in predicting disease duration.
A novel role for S100β has been identified as a biomarker for delirium duration in critically ill patients, which may have implications for refining treatment in intensive care units. Delirium duration is associated with increased mortality rates, and higher levels of S100β on day 1 or day 8 are linked to longer delirium duration.
African-American women with high levels of HSET protein were three times more likely to have shorter overall survival, progression-free survival, and metastasis-free survival compared to those with lower levels. The study found that HSET represents a potential new biomarker for poor breast cancer outcomes in African-American women.
A new method developed by Fred Hutchinson Cancer Center researchers can measure hundreds of proteins in a single assay, paving the way for standardized quantification of the human proteome. This breakthrough could lead to more accurate cancer biomarkers and personalized treatments.
Scientists at UCLA and Emory University have identified a biochemical signal in the blood associated with the faster-progressing form of Parkinson's. The researchers discovered that N8-acetyl spermidine is significantly elevated in rapid progressors, suggesting its potential as an early biomarker for the disease.
Researchers are creating new statistical tools to analyze massive amounts of cancer data and identify hidden relationships between biomarkers. The goal is to develop a framework that can combine continuous and noncontinuous variables, allowing for more accurate insights into the complex nature of cancer.
Researchers have identified a biomarker for sepsis in the blood that can be screened for at a patient's bedside, enabling rapid diagnosis and treatment. This breakthrough has the potential to save thousands of lives by reducing diagnosis time from up to two days to just two hours.
A study published in Neurology found that alpha-synuclein, a protein associated with Lewy bodies, is elevated in the skin of people with Parkinson's disease. This could lead to the development of a biomarker for early diagnosis and improved treatment options.
Researchers will investigate methylation markers in blood to predict chronic depression with a $3 million NIH grant. The findings may lead to more tailored treatment plans and improved management of the condition affecting nearly 15 million American adults.
A new study from Japan found that individuals with a history of kidney stones have significantly increased levels of inflammatory chemokines GRO and CXCL1, while those without kidney stones have higher levels of anti-inflammatory cytokine IL-4. This research may lead to the development of new therapeutic drugs for kidney stone formation.
A novel biomarker, 2-aminoadipic acid (2-AAA), has been identified that can predict diabetes risk up to 12 years in advance. Individuals with high levels of 2-AAA concentrations had a fourfold risk of developing diabetes compared to those with lower levels.
A new study by Robert Gerszten and colleagues has identified 2-aminoadipic acid as a biomarker for Type 2 diabetes risk. Individuals with elevated levels of this metabolite were found to be at higher risk of developing T2D, with detectable levels present up to 12 years before disease onset.
Researchers have identified a metabolite as a biomarker of diabetes risk, revealing that individuals with increased levels are more likely to develop type 2 diabetes. Additionally, the study found that a specific genetic mutation affects muscle performance in elite endurance athletes by altering calcineurin signaling.
A new study published in the Journal of Neurotrauma found that low-level blast explosions can cause symptoms similar to sports concussions, including neurocognitive deficits and self-reported symptoms. The research, conducted on a group of soldiers called 'breachers', identified biomarkers capable of detecting changes in this population.
Researchers tracked changes in gene expression to predict kidney damage severity in children with urinary tract obstruction. The study identified specific genes associated with the degree of obstruction, which could help identify children at risk of chronic kidney disease and permanent organ damage.
A new biomarker strategy using troponin and copeptin has the potential to change clinical practice with high patient safety, according to the BIC-8 trial. The strategy significantly increased emergency room discharge rates among patients with suspected ACS.
Researchers at the University of Pennsylvania School of Medicine have developed a comprehensive test for protein biomarkers in spinal fluid that shows prognostic and diagnostic value in early stages of Parkinson's disease. The study found that patients with lower levels of tau and alpha synuclein had greater motor dysfunction, while th...
Researchers analyzed cerebrospinal fluid biomarkers in patients with early-stage Parkinson's disease (PD) and healthy controls. Lower levels of Alzheimer's beta-1-42 and tau proteins were found in PD patients, associated with motor severity. The study suggests that these biomarkers have prognostic potential for early-stage PD.
A study published in Molecular Psychiatry found RNA biomarkers in blood associated with suicidal thoughts in patients with bipolar disorder. The researchers identified SAT1 and other markers that were significantly elevated in the blood of both bipolar disorder patients and those who had committed suicide.
A study led by Dr. Elizabeth Osuch found a correlation between the activation of the putamen region in the brain and bipolar disorder symptoms. The discovery may lead to a definitive biological marker for differentiating between major depressive disorder and bipolar disorder, ultimately improving diagnosis and treatment.
A study identified a potential biomarker for Alzheimer's disease in cerebral spinal fluid, suggesting the condition may be detectable a decade before symptoms appear. Researchers hope to find treatments that can prevent or slow the progression of the disease.
The lack of investment in tumor biomarker research, inconsistent regulatory rules, and inadequate payment have created a vicious cycle preventing the development and testing of reliable biomarker tests. Experts recommend reforms to break this cycle and increase the value of tumor biomarker tests.
A clinical study on reduced toxicant prototype cigarettes is investigating whether reducing smoke toxicant exposure affects biomarkers of biological effect. The six-month study, involving 260 healthy adult subjects, aims to assess the longer-term impact of these cigarettes on biological effects.
Researchers at the National Human Genome Research Institute identified biomarkers of kidney damage and demonstrated that antioxidant therapy protected kidney function in mice. These findings offer new tools for monitoring disease progression and may pave the way for clinical trials for patients with methylmalonic acidemia.
Researchers have discovered four biomarkers that characterize the non-genetic form of amyotrophic lateral sclerosis (ALS), a devastating motor neuron disease. These biomarkers could lead to earlier and more accurate diagnostics, as well as new directions for therapeutic research.
A Loyola University Medical Center study found that treating acid reflux through laparoscopic anti-reflux surgery could help prevent chronic rejection in lung transplant patients. Certain biomarkers in lung fluid can predict BOS and immune system activity.
Research reveals a gene called CPT1A, which regulates fat breakdown in the liver, may increase risk of heart disease when methylated. The study found elevated levels of bad cholesterol and triglycerides, and lower adiponectin levels in patients with this genetic switch turned off.
Researchers at the University of Alaska Fairbanks have discovered a novel biomarker that can accurately measure long-term sugar intake from a single blood or hair sample. This breakthrough tool is distinct in corn and sugar cane, which are sources of nearly all sugars found in sugar-sweetened beverages.
Researchers found that a combination of two proteins, S100B and apoA-1, helps most accurately classify head injuries. This study provides significant evidence for the potential use of blood tests in diagnosing mild traumatic brain injury.
New antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis by detecting the disease in patients who test negative for existing diagnostic antibodies. The study found that these biomarkers were present in both early and seronegative disease, indicating their potential to close the diagnostic gap in RA.